Artisan Partners Limited Partnership bought a new stake in shares of Cardinal Health, Inc. (NYSE:CAH) during the 2nd quarter, according to the company in its most recent disclosure with the SEC. The fund bought 538,409 shares of the company’s stock, valued at approximately $41,953,000. Artisan Partners Limited Partnership owned approximately 0.17% of Cardinal Health at the end of the most recent reporting period.

Other institutional investors have also made changes to their positions in the company. Bronfman E.L. Rothschild L.P. raised its stake in Cardinal Health by 31.8% during the 2nd quarter. Bronfman E.L. Rothschild L.P. now owns 1,583 shares of the company’s stock valued at $123,000 after acquiring an additional 382 shares in the last quarter. JFS Wealth Advisors LLC raised its stake in Cardinal Health by 14.3% during the 2nd quarter. JFS Wealth Advisors LLC now owns 1,949 shares of the company’s stock valued at $152,000 after acquiring an additional 244 shares in the last quarter. Dupont Capital Management Corp bought a new stake in Cardinal Health during the 2nd quarter valued at $164,000. First Personal Financial Services raised its stake in Cardinal Health by 127.5% during the 2nd quarter. First Personal Financial Services now owns 2,209 shares of the company’s stock valued at $172,000 after acquiring an additional 1,238 shares in the last quarter. Finally, Alpha Windward LLC increased its position in shares of Cardinal Health by 0.7% during the 2nd quarter. Alpha Windward LLC now owns 2,299 shares of the company’s stock valued at $179,000 after purchasing an additional 17 shares during the period. 87.63% of the stock is currently owned by hedge funds and other institutional investors.

Cardinal Health, Inc. (CAH) opened at 66.44 on Wednesday. The firm has a market capitalization of $21.03 billion, a PE ratio of 16.49 and a beta of 0.85. The company has a 50 day moving average price of $67.69 and a 200-day moving average price of $74.72. Cardinal Health, Inc. has a one year low of $62.70 and a one year high of $84.88.

Cardinal Health (NYSE:CAH) last posted its quarterly earnings results on Wednesday, August 2nd. The company reported $1.31 earnings per share for the quarter, beating the Zacks’ consensus estimate of $1.24 by $0.07. The company had revenue of $32.97 billion for the quarter, compared to the consensus estimate of $32.73 billion. Cardinal Health had a return on equity of 26.20% and a net margin of 0.99%. The firm’s quarterly revenue was up 5.0% on a year-over-year basis. During the same quarter in the prior year, the business posted $1.14 EPS. On average, equities analysts predict that Cardinal Health, Inc. will post $4.96 EPS for the current year.

The business also recently declared a quarterly dividend, which will be paid on Sunday, October 15th. Stockholders of record on Monday, October 2nd will be paid a $0.4624 dividend. This represents a $1.85 dividend on an annualized basis and a dividend yield of 2.79%. The ex-dividend date of this dividend is Friday, September 29th. Cardinal Health’s dividend payout ratio (DPR) is currently 45.79%.

TRADEMARK VIOLATION WARNING: “Artisan Partners Limited Partnership Takes $41.95 Million Position in Cardinal Health, Inc. (CAH)” was originally published by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are accessing this piece on another publication, it was illegally stolen and reposted in violation of international copyright legislation. The original version of this piece can be accessed at https://www.thecerbatgem.com/2017/09/20/artisan-partners-limited-partnership-takes-41-95-million-position-in-cardinal-health-inc-cah.html.

Several equities analysts have recently issued reports on the company. BidaskClub cut Cardinal Health from a “hold” rating to a “sell” rating in a research report on Friday, August 4th. Credit Suisse Group lowered their price target on Cardinal Health from $87.00 to $81.00 and set an “outperform” rating on the stock in a research report on Thursday, August 3rd. Royal Bank Of Canada assumed coverage on Cardinal Health in a research report on Tuesday. They set a “sector perform” rating and a $72.00 price target on the stock. UBS AG reiterated a “neutral” rating and set a $76.00 price target (down from $79.00) on shares of Cardinal Health in a research report on Wednesday, August 9th. Finally, Robert W. Baird reiterated a “hold” rating and set a $73.00 price target on shares of Cardinal Health in a research report on Sunday. Two research analysts have rated the stock with a sell rating, twelve have issued a hold rating and four have issued a buy rating to the company. Cardinal Health has a consensus rating of “Hold” and an average target price of $76.81.

Cardinal Health Company Profile

Cardinal Health, Inc is a healthcare services and products company. The Company operates through two segments: Pharmaceutical and Medical. The Pharmaceutical segment distributes branded and generic pharmaceutical, specialty pharmaceutical, over-the-counter healthcare and consumer products. This segment also operates nuclear pharmacies and cyclotron facilities; provides pharmacy management services to hospitals, as well as medication therapy management and patient outcomes services to hospitals, other healthcare providers and payers, and provides services to healthcare companies.

Institutional Ownership by Quarter for Cardinal Health (NYSE:CAH)

Receive News & Stock Ratings for Cardinal Health Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardinal Health Inc. and related stocks with our FREE daily email newsletter.